FDA clears Hyperfine software update for low-field brain images

Hyperfine announced the clearance of the ninth generation of AI-powered Swoop system software. This advanced software significantly reduces scan times across multiple MR sequences without sacrificing image quality. The U.S. Food and Drug Administration or FDA, clearance of this software further solidifies Hyperfine as a leader in AI-powered health technology. These scan time reductions may enable Swoop system images to help speed up the diagnostic process in acute care settings, which is crucial for time-sensitive medical conditions such as stroke, where every second counts. Reducing the overall acquisition time for sequences can also decrease the negative impact of patient motion on image quality.